TrialCritical care (London, England)2003

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients.

Nikolaos Markou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.